lu.ma Open in urlscan Pro
2606:4700:10::ac43:938  Public Scan

Form analysis
0 forms found in the DOM

Text Content

05:08 MESZ
Entdecken
Anmelden
Veranstaltet von
Merck Digital Sciences Studio

Ahmet-Hamdi Cavusoglu

Alexa
Geof Hannigan
Anita Manik
Kontaktieren Sie den Gastgeber
Veranstaltung melden


MERCK DIGITAL SCIENCES STUDIO GRADUATION SHOWCASE

Veranstaltet von Merck Digital Sciences Studio & 4 anderen
Aug
6
Dienstag, 6. August
14:00 - 17:00 GMT-4

Registrieren, um die Adresse zu sehen
New York, New York
Registrierung
Du bist eingeladen
Wir würden uns freuen, wenn du dabei bist.
Willkommen! Um an der Veranstaltung teilzunehmen, registrieren Sie sich bitte
unten.
Einladung annehmen
Ablehnen

Sie werden aufgefordert, den Token-Besitz mit Ihrer Wallet zu verifizieren.
Über die Veranstaltung

Join us as our latest batch of companies creating the future for the digital
enablement of drug discovery and development graduate. The Merck Digital
Sciences Studio Graduation Showcase will offer you a chance to see the
groundbreaking work of 12 teams from our current cohort. This event promises to
be a unique opportunity to see firsthand the cutting-edge advancements these
teams are bringing to the digital sciences landscape.

During this showcase, attendees will have the chance to engage with the leaders
of these ventures, gain insights into their methods, solutions, and the
potential impact of their work on biopharma and beyond as well as hear from VCs
working in this space.

We're excited to bring together a community of individuals passionate about the
future. Don't miss this chance to connect with pioneers at the forefront of
digital innovation and to be among the first to learn about the next big
breakthroughs. We look forward to welcoming you to what promises to be a
fruitful and thought-provoking afternoon.

About MDS Studio

The MDS Studio is a collaboration between Merck and the New Jersey Innovation
Institute (NJII), a New Jersey Institute of Technology corporation, with
investments from the Merck Global Health Innovation Fund, Northpond Ventures and
McKesson Ventures. Technology support is provided by Microsoft for Startups.

About McDermott Will & Emery

McDermott Will & Emery partners with leaders around the world to fuel missions,
knock down barriers and shape markets. Our team works seamlessly across
practices and industries to deliver highly effective solutions that propel
success. More than 1,400 lawyers strong, we bring our personal passion and legal
prowess to bear in every matter for our clients and the people they serve.

--------------------------------------------------------------------------------


AGENDA

 * 2:30 - 2:45 - Introduction & Welcome

 * 2:45 - 3:15 - Startup Quick Pitches

 * 3:15 - 4:15 - VC Panel Discussion

 * 4:15 - 4:45 - Startup Quick Pitches

 * 4:45 - 5:00 - Merck Leadership Thanks & Closeout

--------------------------------------------------------------------------------

Join us for our Open Showcase & Networking from 5 - 8p!

Graduation Showcase Reception

--------------------------------------------------------------------------------


MERCK DIGITAL SCIENCES STUDIO TEAMS IN COHORT 2


APERTURE BIO COMBINING THE STUDY OF PROTEINS AND THEIR FUNCTIONS TO FACILITATE
THE DEVELOPMENT OF CANCER DRUGS.


ASCENT BIO OPTIMIZING THE SEARCH FOR CANDIDATE MOLECULES WITH A PRETRAINED, DEEP
LEARNING, API-ORIENTED PLATFORM.


BRAINIFY.AI OPTIMIZING DEPRESSION TREATMENT THROUGH AI-DRIVEN PRECISION
PSYCHIATRY.


DANNCE.AI TRANSFORMING PATIENT CARE AND TREATMENT VIA ADVANCED 3D POSE TRACKING
AI TO CATEGORIZE PATIENT MOBILITY AND BEHAVIORS.


DEEPSEQ.AI DECODING PROTEIN GRAMMAR TO EXPEDITE LEAD DISCOVERY AND ENSURE
SUCCESSFUL CLINICAL ENTRY.


E9 GENOMICS MAKING GENOMIC INSIGHTS INSTANTANEOUS, SIMPLE, AND ACCESSIBLE AT
EVERY STAGE OF RESEARCH AND THERAPEUTIC DEVELOPMENT.


ORBITS ONCOLOGY BRING PATIENTS INTO THE HEART OF CANCER DRUG DEVELOPMENT AND
PERSONALIZED MEDICINE.


PRISM.BIO HARNESSING THE POWER OF CUTTING-EDGE GENERATIVE AI TO PROVIDE
EVIDENCE-BASED INSIGHTS.


PROVIDENTIA TECHNOLOGIES PREDICTING DRUG TOXICITY EARLY WITH SYNTHETIC CELL
MEMBRANES AND MACHINE LEARNING ALGORITHMS.


READOUTAI ASSESSING THE FUTURE OF PRECLINICAL AND CLINICAL TRIALS, SAVING TIME
AND MONEY FOR RESEARCHERS AND COMPANIES.


SERINUS BIOSCIENCES DESIGNING RATIONAL COMBINATION THERAPIES USING AI TO
OVERCOME CLINICALLY-RELEVANT DISEASE RESISTANCE MECHANISMS


VCREATE HARNESSING MACHINE LEARNING AND HIGH-THROUGHPUT ASSAYS TO DISCOVER
POTENT T-CELL RECEPTORS FOR CURRENTLY UNTREATABLE CANCERS.

Ort
Bitte registrieren Sie sich, um den genauen Ort dieser Veranstaltung zu sehen.
New York, New York

Veranstaltet von
Merck Digital Sciences Studio

Ahmet-Hamdi Cavusoglu

Alexa
Geof Hannigan
Anita Manik
Kontaktieren Sie den Gastgeber
Veranstaltung melden
Was gibt's NeuesEntdeckenPreiseHilfe

Veranstalten Sie Ihr Event mit Luma ↗